-
The views expressed herein do not constitute research, investment advice or trade recommendations, do not necessarily represent the views of all AB portfolio-management teams and are subject to change over time.
Value stocks have bounced back with gusto outside the US. But can it last?
While the AI-driven rally in US mega-cap growth stocks grabbed attention in 2025, a very different story was unfolding far from Wall Street. Outside the US, from Europe to Japan, value stocks shed their perennial underdog status to stage a dramatic recovery—one that we think may just be getting started.
Global equity markets were full of surprises this year. Japanese and European stocks outpaced US peers. The MSCI EAFE Value Index of non-US equities surged by 36.5% through November (Display) in US-dollar terms, outperforming the MSCI EAFE Growth and the broad index. It was a mirror image of the US market, where growth stocks remained on top.
Past performance does not guarantee future results.
As of November 30, 2025
Source: FTSE Russell, MSCI, S&P and AllianceBernstein (AB)
Several catalysts helped awaken value stocks, which began the year with exceptionally cheap valuations: First, companies in the value universe generally delivered earnings growth above expectation. Second, key value-oriented industries performed especially well, including European banks—as a steep yield curve buoyed profitability—and defense. Third, Asian corporate governance reforms are gaining traction.
In Europe, regional defense spending has increased amid heightened geopolitical tensions related to the Russia-Ukraine war and uncertainty over the US defense umbrella. EU defense spending rose by 19% in 2024 to €343 billion, or 1.9% of GDP, according to the European Council. The North Atlantic Treaty Organization is pressing its members to allocate at least 3% of GDP for defense budgets over the coming years, which could add another €220 billion a year to European military spending.
That translates to a big business boost for large, regional defense contractors, which can support stable cash flows and dividend payouts. These companies are prominent members of the value cohort.
Meanwhile, a new culture of corporate governance reform is taking root across Asia. China, South Korea and Japan are pushing reforms to boost shareholder value. In Japan, regulators are encouraging companies to reduce cross-shareholdings and deploy hoarded cash to boost operating leverage and streamline balance sheets. These moves could prompt a recovery in select Japanese companies with attractive valuations and a clear path to improve profitability.
China, too, is pressing companies to improve governance via the 2024 nine-point guidelines. These moves have helped lift profitability, dividends and buybacks to record highs. South Korean initiatives are in full swing through the “value up” program, which aims to incentivize improved capital management and operating performance. The goal: to boost valuations in a South Korean market that has had an exceptionally high proportion of cheaply valued stocks for years.
After such a strong year, it’s natural for investors to question the staying power of non-US value stocks. We think there are good reasons to believe that the trend can continue.
First, the catalysts above are long-term trends that should continue to evolve. Defense spending in Europe is being driven by seismic geopolitical shifts that aren’t going away. Corporate governance reform is a multi-year process; while policy-driven changes can be erratic, we expect developments in Asia to create a virtuous circle, as more companies discover the benefits of cleaning up their businesses for shareholders.
Second, we’re seeing signs of other value-friendly themes developing. Examples include rising demand for commercial aircraft, a recovery in depressed agricultural commodity prices and the recovery of healthcare R&D spending from post-pandemic pressures. These trends support select opportunities in value-oriented companies with healthier businesses than perceived.
Third, new forces could propel value market segments that haven’t yet rebounded. For example, a continued weakening of the US dollar could support emerging-market stocks, which have not yet fully participated in the value rally.
Even after this year’s rebound, ex-US value stocks still offer attractive discounts for investors by several measures. The MSCI EAFE Value’s price-to-forward-earnings ratio trades at a discount of 43% to growth stocks and 21% to the broader market (Display).
Past performance and current analysis do not guarantee future results.
*P/FE (next 12 months) since June 1999. Based on MSCI EAFE Value Index, MSCI EAFE Growth Index and MSCI EAFE Index, representing the broad market.
As of November 30, 2025
Source: Bloomberg, FactSet, LSEG I/B/E/S, MSCI, S&P, TOPIX, The Washington Service and AB
Free-cash-flow (FCF) yields also tell a compelling value story. We believe the FCF yield is an important indicator of whether a company is undervalued or overvalued based on its cash-generating ability. Our research shows a widening gap between FCF yields and government bond yields in the US versus Europe and Japan, indicating stronger compensation potential for risk-taking and better value opportunities. US equities have a negative real FCF yield spread versus Treasuries, signaling stretched valuations.
As we see it, the FCF yield analysis bolsters the case for allocating to value equities outside the US, particularly at a time of elevated market concentration in the US and increasing questions about the fragility of AI-driven market conditions.
Markets are fraught with risk as we enter 2026. That’s why a selective and risk-aware approach remains paramount. We think investors should search for value opportunities in three areas: companies undergoing positive changes, businesses with underappreciated sustainable competitive advantages and firms that benefit from improving industry competitive dynamics.
After years of unforgiving market conditions, disciplined value investing is starting to pay off. It’s not too late to diversify your equity allocation by increasing exposure to value stocks around the world with compelling recovery stories that represent powerful return potential.
The views expressed herein do not constitute research, investment advice or trade recommendations, do not necessarily represent the views of all AB portfolio-management teams and are subject to change over time.
MSCI makes no express or implied warranties or representations, and shall have no liability whatsoever with respect to any MSCI data contained herein.
The MSCI data may not be further redistributed or used as a basis for other indices or any securities or financial products. This report is not approved, reviewed or produced by MSCI.
Investment involves risk. The information contained here reflects the views of AllianceBernstein L.P. or its affiliates and sources it believes are reliable as of the date of this publication. AllianceBernstein L.P. makes no representations or warranties concerning the accuracy of any data. There is no guarantee that any projection, forecast or opinion in this material will be realized. Past performance does not guarantee future results. The views expressed here may change at any time after the date of this publication. This article is for informational purposes only and does not constitute investment advice. AllianceBernstein L.P. does not provide tax, legal or accounting advice. It does not take an investor's personal investment objectives or financial situation into account; investors should discuss their individual circumstances with appropriate professionals before making any decisions. This information should not be construed as sales or marketing material or an offer of solicitation for the purchase or sale of, any financial instrument, product or service sponsored by AllianceBernstein or its affiliates. This presentation is issued by AllianceBernstein Hong Kong Limited (聯博香港有限公司) and has not been reviewed by the Securities and Futures Commission.